CHEMTURA CORP's ticker is CHMT and the CUSIP is 163893209. A total of 151 filers reported holding CHEMTURA CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $10,287,000 | -73.8% | 307,993 | -73.9% | 0.02% | -74.7% |
Q4 2016 | $39,201,000 | -30.9% | 1,180,763 | -31.7% | 0.08% | -31.2% |
Q3 2016 | $56,720,000 | -52.0% | 1,728,747 | -61.4% | 0.11% | -5.2% |
Q2 2016 | $118,218,000 | +97.9% | 4,481,374 | +98.0% | 0.12% | -4.2% |
Q1 2016 | $59,743,000 | -6.3% | 2,262,988 | -3.2% | 0.12% | -8.4% |
Q4 2015 | $63,763,000 | -4.4% | 2,338,217 | +0.3% | 0.13% | -8.4% |
Q3 2015 | $66,724,000 | +5.2% | 2,331,375 | +4.1% | 0.14% | +13.5% |
Q2 2015 | $63,407,000 | -11.6% | 2,239,722 | -14.8% | 0.13% | -10.6% |
Q1 2015 | $71,742,000 | -20.2% | 2,628,889 | -27.7% | 0.14% | -23.8% |
Q4 2014 | $89,922,000 | +17.9% | 3,636,157 | +11.2% | 0.18% | +12.8% |
Q3 2014 | $76,276,000 | -6.3% | 3,269,458 | +5.0% | 0.16% | -9.4% |
Q2 2014 | $81,370,000 | +5.0% | 3,114,059 | +1.7% | 0.18% | +35.1% |
Q1 2014 | $77,459,000 | +9.9% | 3,062,814 | +21.3% | 0.13% | +6.3% |
Q4 2013 | $70,489,000 | +47.9% | 2,524,667 | +21.8% | 0.13% | +35.5% |
Q3 2013 | $47,644,000 | +10.1% | 2,072,368 | -2.8% | 0.09% | -1.1% |
Q2 2013 | $43,261,000 | – | 2,131,079 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CYRUS CAPITAL PARTNERS, L.P. | 2,089,464 | $48,747,000 | 6.50% |
RESTRUCTURING CAPITAL ASSOCIATES LP | 338,080 | $7,887,000 | 5.78% |
Paradice Investment Management LLC | 835,850 | $19,500,000 | 5.07% |
ROCKSHELTER CAPITAL MANAGEMENT LLC | 782,320 | $18,252,000 | 4.89% |
Sandhill Capital Partners LLC | 405,261 | $9,455,000 | 3.37% |
Clearline Capital LP | 880,639 | $20,545,000 | 3.31% |
WS MANAGEMENT LLLP | 4,338,935 | $101,227,000 | 3.25% |
Corsair Capital Management | 2,250,976 | $52,516,000 | 2.70% |
LionEye Capital Management LLC | 1,400,000 | $32,662,000 | 1.79% |
Tahithromos, L.L.C. | 277,999 | $6,486,000 | 1.68% |